Latest Logistics News

Reedy Lagoon Corporation reports promising soil sampling results at its Burracoppin Gold project while seeking partners for its iron venture amid challenging market conditions.

Northern Minerals reports a 15% increase in its Wolverine Deposit resource and secures $28 million in funding, advancing its Browns Range heavy rare earths project amid ongoing feasibility studies.

Tartana Minerals reports robust copper sulphate sales and completes a significant acquisition, positioning itself as a leading explorer and developer in Far North Queensland.

Akora Resources reports strong progress at its Bekisopa Iron Ore Project in Madagascar, highlighted by successful drilling results, completion of key technical studies, and official support from the Malagasy government. The company is on track to deliver a Pre-Feasibility Study by Q1 2025, aiming to produce high-grade direct shipping ore for steelmakers focused on decarbonisation.

Diatreme Resources has made significant strides in its silica sand ventures, signing a non-binding offtake MOU with Mitsui & Co and enhancing its leadership team. The company also reports strong cash reserves and ongoing environmental and community engagement efforts.

DMC Mining Limited moves closer to ASX re-admission as Guinea reopens its cadastral licensing system, enabling imminent exploration licenses for key projects. The company also strengthens its leadership team and secures additional financing to support upcoming operations.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

Mesoblast Limited is set to launch Ryoncil®, the first FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease, backed by a recent $160 million financing that strengthens its commercial and clinical development efforts.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.

Botanix Pharmaceuticals has initiated the commercial rollout of Sofdra, its FDA-approved treatment for primary axillary hyperhidrosis, with first prescriptions dispensed and a fully trained sales force deployed. The company anticipates meaningful revenue growth starting in the first quarter of 2025, backed by strong payer contracts and a robust cash position.

QEM Limited has marked significant progress in its Julia Creek Vanadium and Energy Project, securing key government approvals and raising $2.76 million to advance development and environmental studies.

TerraCom Limited reported resilient coal sales of 1.6 million tonnes for the December quarter despite weather disruptions, while advancing its Moorlands Thermal Coal Project and maintaining a fully franked dividend.